Trade Summary

2 days ago, EDGEMOND JAMES, serving as CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $546.28 per share, for a total transaction value of $5,462,824.46. Following this transaction, EDGEMOND JAMES now holds 18,876 shares of UTHR.

This sale represents a 34.63% decrease in EDGEMOND JAMES's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 4:31 PM ET, 1 day after the trade was made.

UNITED THERAPEUTICS Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.